Skip to Content

South American Gold Corp SAGD

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SAGD is trading at a 42% discount.
Price
$0.00
Fair Value
$6.20
Uncertainty
Extreme
1-Star Price
$5.12
5-Star Price
$9.17
Economic Moat
Lqmt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SAGD is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$0.14
Volume/Avg
16,000 / 66,200

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

South American Gold Corp owns, operates, and invests in cannabis-related products, services, and technology. The company is focused on tech related as well as more traditional physical product operations that will provide a diverse base of products and service offerings.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
SAGD
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
SAGD
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
−0.81
Quick Ratio
No chart available

Profitability

Metric
SAGD
Return on Assets (Normalized)
−3,487.36%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRKjwrnzhlvQxzzk$71.2 Bil
ZTS
Zoetis Inc Class AMxmcpgpphBhfyd$68.3 Bil
HLN
Haleon PLC ADRGtdgxmxMdlh$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRTgkmvbvfHwr$14.5 Bil
VTRS
Viatris IncTnjtzvplLrrmm$13.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRNkrgbysCzf$11.9 Bil
CTLT
Catalent IncMmylzpnbRfjgsw$10.1 Bil
PRGO
Perrigo Co PLCGkhxfybpYgflq$4.1 Bil
CURLF
Curaleaf Holdings IncKjnfxpztcJybn$3.6 Bil
PBH
Prestige Consumer Healthcare IncLrbbjprTksgxbn$3.5 Bil

Sponsor Center